U.S., Jan. 14 -- An application to own the trademark for 'INHIBIKASE' has been filed on Jul. 30, 2025.
Owner(s):
Inhibikase Therapeutics, Inc.; 1000 N. West Street, Suite 1200, , DELAWARE
Goods and/or Services:
For: Pharmaceutical preparations for the treatment of cardiopulmonary diseases
Class(es): 005, 006, 018, 044, 046, 051, 052
For: Pharmaceutical research and development; Medical and scientific research in the field of cardiopulmonary disease; Scientific laboratory services; Scientific and technological services, namely, pre-clinical and clinical evaluation in the field of cardiopulmonary disease; Biological research
Class(es): 100, 101
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2026...